Genetic Technologies Ltd (GENE)
2.31
-0.01
(-0.43%)
USD |
NASDAQ |
Apr 22, 16:00
2.345
+0.04
(+1.52%)
After-Hours: 20:00
Genetic Technologies Cash from Investing (TTM): 0.0446M for June 30, 2020
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
Alterity Therapeutics Ltd | -0.0044M |
Kazia Therapeutics Ltd | 0.00 |
Immutep Ltd | -0.0131M |
Opthea Ltd | -0.0192M |
Mesoblast Ltd | -0.194M |